ReviewCurrent pain and headache reports2026
An Updated Review of Utilization Patterns of Sacroiliac Joint Interventions in the Fee-for-service (ffs) Medicare Population from 2000 to 2022.
Review in Current pain and headache reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purpose of the reviewThis updated review evaluates utilization patterns of sacroiliac joint (SIJ) interventions, including SIJ injections, radiofrequency neurolysis, and SIJ fusion, using data from the Centers for Medicare and Medicaid Services (CMS) and Physician Supplier Procedure Summary (PSPS) database. RECENT
findingsBetween 2019 and 2022, Medicare data revealed a notable significant decline in SIJ intervention utilization, with a cumulative drop of 28.9% and an annual decrease of 10.7% per 100,000 beneficiaries. This represents a stark contrast to the minimal 0.4% annual decline observed from 2010 to 2019. The most significant reduction occurred from 2019 to 2020 (− 18.7%), coinciding with the onset of the COVID-19 pandemic. Utilization declined slightly from 2020 to 2021 (− 1.1%), then more sharply again from 2021 to 2022 (− 11.5%). These patterns mirror trends seen in similar studies on epidural and facet joint interventions, which often evaluate SIJ procedures in tandem. While the Medicare population increased by 63.3% from 2000 to 2022, SIJ injections rose by 281% overall during the same period, with an annual increase of 6.3%. However, post-COVID-19 (2019–2022), there was a 13.5% overall decrease in SIJ procedures, averaging a 4.7% annual decline. The largest drop occurred in 2020 (− 19.2%), followed by an 8.3% rebound in 2021, and a subsequent 1.2% decline in 2022. These findings highlight shifting trends in interventional pain management, particularly in response to public health and economic disruptions.
Indexed as
Identifiers
41838245What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.